Mark E. Kaufmann
Algemeen Directeur bij The Linguist Institute, Inc.
Actieve functies van Mark E. Kaufmann
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
The Linguist Institute, Inc.
The Linguist Institute, Inc. Internet Software/ServicesTechnology Services The Linguist Institute, Inc. operates web and mobile language learning platform. It provides e-learning services. The company was founded by Mark E. Kaufmann and Steven M. Kaufman in 2007 and is headquartered in West Vancouver, Canada. | Algemeen Directeur | 01-01-2007 | - |
Oprichter | 01-01-2007 | - |
Loopbaan van Mark E. Kaufmann
Eerdere bekende functies van Mark E. Kaufmann
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ARDELYX, INC. | Comptroller/Controller/Auditor | 15-09-2017 | 12-03-2020 |
Financieel Directeur/CFO | 01-05-2014 | 12-03-2020 | |
Corporate Officer/Principal | 02-09-2011 | 02-09-2011 | |
Treasurer | 01-12-2016 | 12-03-2020 | |
Allostera Pharma, Inc.
Allostera Pharma, Inc. Medical DistributorsDistribution Services Allostera Pharma Inc. is a biopharmaceutical company that has developed an entirely new class of drugs, called Allosteramers™. Allosteramers™ have three main properties: 1) they are “allosteric”, meaning they do not bind to the same site as traditional drugs, potentially providing better safety, efficacy and an entirely new set of patentable intellectual properties, 2) they can have predictable and consistent drug properties, and 3) they are designed to be orally available. Using its Module X technology platform, Allostera has developed a pipeline of seven novel Allosteramers™ against different targets primarily focused on inflammation and autoimmunity including APG2305, a drug inhibiting the IL23 receptor, one of the most important targets in the autoimmune disease field. APG2305 has demonstrated oral activity in animal models of autoimmune diseases. | Algemeen Directeur | 09-07-2009 | 09-09-2013 |
President | 09-07-2009 | 09-09-2013 | |
CelMed BioSciences, Inc.
CelMed BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Celmed BioSciences Inc. is a biopharmaceutical company. The company is engaged in developing breakthrough products to treat cancer. The company offers rational drug design and pharmacogenomic concepts to improve cancer patient care. Products of the company include Theralux and NB1011 which offers “Trojan horse solution' to treat cancer. The company is headquartered in Saint-Laurent, Canada. | President | - | 28-11-2006 |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01-01-1994 | - |
Conceptis Technologies, Inc.
Conceptis Technologies, Inc. Internet Software/ServicesTechnology Services Part of WebMD Health Corp., Conceptis Technologies, Inc. is a Canadian company that provides online and offline medical education and promotion aimed at physicians. The company is based in Montréal, Canada. Conceptis Technologies was acquired by Emdeon Corp. on December 02, 2005 for $19.86 million. | Financieel Directeur/CFO | - | - |
Nexia Biotechnologies, Inc.
Nexia Biotechnologies, Inc. BiotechnologyHealth Technology Nexia Biotechnologies produces therapeutic proteins and other biomaterials for the treatment of serious disease | Corporate Officer/Principal | - | - |
Opleiding van Mark E. Kaufmann
Harvard University | Undergraduate Degree |
Stephen M. Ross School of Business | Masters Business Admin |
Statistieken
Internationaal
Canada | 6 |
Verenigde Staten | 5 |
Operationeel
Corporate Officer/Principal | 3 |
President | 2 |
Chief Executive Officer | 2 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Technology Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ARDELYX, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
CelMed BioSciences, Inc.
CelMed BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Celmed BioSciences Inc. is a biopharmaceutical company. The company is engaged in developing breakthrough products to treat cancer. The company offers rational drug design and pharmacogenomic concepts to improve cancer patient care. Products of the company include Theralux and NB1011 which offers “Trojan horse solution' to treat cancer. The company is headquartered in Saint-Laurent, Canada. | Health Technology |
Allostera Pharma, Inc.
Allostera Pharma, Inc. Medical DistributorsDistribution Services Allostera Pharma Inc. is a biopharmaceutical company that has developed an entirely new class of drugs, called Allosteramers™. Allosteramers™ have three main properties: 1) they are “allosteric”, meaning they do not bind to the same site as traditional drugs, potentially providing better safety, efficacy and an entirely new set of patentable intellectual properties, 2) they can have predictable and consistent drug properties, and 3) they are designed to be orally available. Using its Module X technology platform, Allostera has developed a pipeline of seven novel Allosteramers™ against different targets primarily focused on inflammation and autoimmunity including APG2305, a drug inhibiting the IL23 receptor, one of the most important targets in the autoimmune disease field. APG2305 has demonstrated oral activity in animal models of autoimmune diseases. | Distribution Services |
Nexia Biotechnologies, Inc.
Nexia Biotechnologies, Inc. BiotechnologyHealth Technology Nexia Biotechnologies produces therapeutic proteins and other biomaterials for the treatment of serious disease | Health Technology |
Conceptis Technologies, Inc.
Conceptis Technologies, Inc. Internet Software/ServicesTechnology Services Part of WebMD Health Corp., Conceptis Technologies, Inc. is a Canadian company that provides online and offline medical education and promotion aimed at physicians. The company is based in Montréal, Canada. Conceptis Technologies was acquired by Emdeon Corp. on December 02, 2005 for $19.86 million. | Technology Services |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
The Linguist Institute, Inc.
The Linguist Institute, Inc. Internet Software/ServicesTechnology Services The Linguist Institute, Inc. operates web and mobile language learning platform. It provides e-learning services. The company was founded by Mark E. Kaufmann and Steven M. Kaufman in 2007 and is headquartered in West Vancouver, Canada. | Technology Services |
- Beurs
- Insiders
- Mark E. Kaufmann
- Ervaring